HMGB1 and familial dilated cardiomyopathy: As the treatment of DCM has not yet been undergone, this research will focus on the proposed therapeutic properties of ART in DCM through modulation of the AGE-RAGE/HMGB-1 signaling pathway with subsequent improvement on oxidative stress, inflammation and fibrosis.